Cc1ccc(C(=O)N[C@@H](C)CN2C3=NC[C@H](C)N3C[C@H]2Cc2ccc(O)cc2)cc1Br
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?